Tan D - Search Results

1

Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B.

Tang Y, Fan R, Lan Z, Xie Q, Zhang J, Liang X, Wang H, Tan D, Cheng J, Chen S, Ning Q, Bai X, Xu M, Chen X, Niu J, Shi J, Ren H, Gao Z, Wang M, Dou X, Hou J, Sun J. Tang Y, et al. Among authors: tan d. J Med Virol. 2023 Feb;95(2):e28501. doi: 10.1002/jmv.28501. J Med Virol. 2023. PMID: 36655747 Clinical Trial.

2

[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

Yao GB, Zhu M, Wang YM, Xu DZ, Tan DM, Chen CW, Hou JL. Yao GB, et al. Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):891-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17313873 Clinical Trial. Chinese.

3

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, Xu JZ, Wang QH, Wei L, Ma H. Jia JD, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):342-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524265 Clinical Trial. Chinese.

4

[Clinical observation on auxiliary treatment with suanzaoren decoction for chronic severe hepatitis].

Zhu HP, Gao ZL, Tan DM. Zhu HP, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Apr;27(4):303-5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007. PMID: 17526166 Clinical Trial. Chinese.

5

[Effect of Suanzaoren decoction on acute hepatic failure in mice].

Zhu HP, Gao ZL, Tan DM, Zhong YD. Zhu HP, et al. Zhongguo Zhong Yao Za Zhi. 2007 Apr;32(8):718-21. Zhongguo Zhong Yao Za Zhi. 2007. PMID: 17608229 Chinese.

6

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Among authors: tan d. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

7

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

Sun J, Xie Q, Tan D, Ning Q, Niu J, Bai X, Fan R, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Jia J, Hou J. Sun J, et al. Among authors: tan d. Hepatology. 2014 Apr;59(4):1283-92. doi: 10.1002/hep.26885. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24382690 Clinical Trial.

8

Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: a randomised open-label trial (OSST trial).

Ning Q, Han M, Sun Y, Jiang J, Tan D, Hou J, Tang H, Sheng J, Zhao M. Ning Q, et al. Among authors: tan d. J Hepatol. 2014 Oct;61(4):777-84. doi: 10.1016/j.jhep.2014.05.044. Epub 2014 Jun 7. J Hepatol. 2014. PMID: 24915612 Clinical Trial.

9

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients.

Liang X, Cheng J, Sun Y, Chen X, Li T, Wang H, Jiang J, Chen X, Long H, Tang H, Yu Y, Sheng J, Chen S, Niu J, Ren H, Shi J, Dou X, Wan M, Jiang J, Xie Q, Shi G, Ning Q, Chen C, Tan D, Ma H, Sun J, Jia J, Zhuang H, Hou J. Liang X, et al. Among authors: tan d. J Gastroenterol Hepatol. 2015 Apr;30(4):748-55. doi: 10.1111/jgh.12835. J Gastroenterol Hepatol. 2015. PMID: 25352300 Clinical Trial.

10

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.

Fan R, Sun J, Yuan Q, Xie Q, Bai X, Ning Q, Cheng J, Yu Y, Niu J, Shi G, Wang H, Tan D, Wan M, Chen S, Xu M, Chen X, Tang H, Sheng J, Lu F, Jia J, Zhuang H, Xia N, Hou J; Chronic Hepatitis B Study Consortium. Fan R, et al. Among authors: tan d. Gut. 2016 Feb;65(2):313-20. doi: 10.1136/gutjnl-2014-308546. Epub 2015 Jan 13. Gut. 2016. PMID: 25586058 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,166 results

Search Page